Milestones

2022

Bora Biologics established and acquired Eden Biologics CDMO assets
Bora acquired TWi Pharmaceuticals

2020

Acquire GSK’s Mississauga, Ontario (Canada) facility

2018

Acquired Impax Laboratories Inc. Taiwan Subsidiary and entered US CDMO market

2017

Invested in Yuta Health to license CHC and OTC products of Eisai and SSP pharmaceutical in Taiwan
Completed initial public offering at Taipei Exchange (GreTai Securities Market)

2014

Bora Pharmaceuticals begins public trading on the GTSM ESB
Acquired Union Chemicals Co., Ltd.
Established official Research and Development Laboratory

2013

Acquired Tainan manufacturing site from Japanese Company

2007

Bora Pharmaceuticals established